Chronic kidney failure unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients older than 18 years old and prevalent in chronic HD for at least three months were included;
Exclusion criteria
Exclusion criteria: Patients with cancer, HIV-positive undergoing antiretroviral therapy, end-stage liver disease, heart failure disease with ejection fraction less than 30%, clinical diagnosis of acute infection, (or using antibiotics), chronic inflammatory diseases, such as systemic lupus erythematosus and chronic obstructive pulmonary disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the serum concentration of MDA ;Reduction in the serum concentration of carbonylated protein | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in posterior wall thickness (hypertrophy);Change in the frequency of presence of atheromatous plaque | — |
Countries
Brazil